Sample Page
Author:
Epoint Healthcare
Posted Date:
March 6, 2026
Sciwind Biosciences Announces Ecnoglutide Injection Approved by China’s National Medical Products Administration (NMPA) for Chronic Weight Management
Epoint Healthcare
March 6, 2026
Sciwind Biosciences Partners with Pfizer China to Commercialize its Biased GLP-1 in China
Epoint Healthcare
February 24, 2026